# TP53/MDM2 provenance review checkpoint

This document records the first TP53/MDM2 elephant provenance review
checkpoint.

## Scope

The checkpoint covers the two current TP53/MDM2 elephant repair queue rows:

- TP53 chain row: `tp53_mdm2_elephant_seed_tp53_chain`
- MDM2 chain row: `tp53_mdm2_elephant_seed_mdm2_chain`

Both rows remain Gate 4 / Gate 5 repair-queue worklist items.

## Review decision

Both TP53/MDM2 elephant rows are recorded as:

- `review_decision = deferred_pending_source`
- `downstream_block_status_after_review = blocked_gate4_gate5`
- `allowed_next_action_after_review = defer_until_stronger_source_evidence_exists`
- `claim_policy_after_review = no_biological_claims_until_validation`
- `claim_status_after_review = repair_worklist`

This checkpoint does not accept an accession-level elephant target ortholog for
either TP53 or MDM2. The target UniProt accessions remain unresolved until a
future explicit provenance review accepts stronger accession-level source
evidence.

## Biological interpretation

The TP53/MDM2 lane is important because it represents a different biological
mode from SIRT6/core3.

SIRT6/core3 is mostly a maintained-or-enhanced repair compatibility lane.
TP53/MDM2 may eventually test a beneficial-breakage mode, where weakening the
MDM2 suppression of TP53 could be biologically interesting.

This checkpoint does not evaluate that hypothesis. It only records that the
current TP53/MDM2 elephant seed rows still lack accepted accession-level target
ortholog provenance.

## Guardrails

This checkpoint does not fetch sequences, does not curate orthologs, does not
call Biohub, does not generate embeddings, does not call Boltz, does not rerun
enrichment or contrast, does not promote Gate 8 or Gate 9, and does not make
biological claims.
